This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Will Senior Housing Softness Impact HCP in Q1 Earnings?
by Zacks Equity Research
HCP's premium MOB and life-sciences portfolio will likely perform well in first-quarter 2019, mitigating the challenges tormenting the senior housing market.
Healthcare Realty Completes MOB Buyouts in Potential Markets
by Zacks Equity Research
Healthcare Realty (HR) completes purchase of four properties, amid soaring popularity for medical-office buildings.
Why Is HCP (HCP) Up 1.2% Since Last Earnings Report?
by Zacks Equity Research
HCP (HCP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Healthcare Realty (HR) Prices Offering of 3.25M Common Stock
by Zacks Equity Research
Healthcare Realty's (HR) latest public offering of common stock will improve its financial flexibility and provide ample scope for deploying capital in accretive acquisitions.
HCP Meets Q4 FFO Estimates, Misses on Revenues, Issues View
by Zacks Equity Research
HCP's fourth-quarter 2018 results marred by continued decline in senior-housing operating portfolio cash net operating income.
HCP (HCP) Q4 FFO Match Estimates
by Zacks Equity Research
HCP (HCP) delivered FFO and revenue surprises of 0.00% and -1.33%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Will Operator Transitions Hit HCP's Occupancy in Q4 Earnings?
by Zacks Equity Research
As HCP remains focused on reducing its Brookdale-portfolio concentration, we anticipate the company to report lower portfolio occupancy in the fourth quarter.
Why Trending Outpatient Care is a Boon for Healthcare REITs
by Devyani Chamria
Amid shift of care to low-cost setting, medical office buildings (MOBs) and outpatient facilities have been creating opportunities for healthcare REITs to park their money.
HCP's Unsecured Debt Rating Notched Up to Baa1 by Moody's
by Zacks Equity Research
HCP's senior unsecured debt rating has been bumped up by a notch to Baa1 by Moody's. Moreover, the rating firm's outlook for the company has been maintained at stable.
LXP vs. HCP: Which Stock Is the Better Value Option?
by Zacks Equity Research
LXP vs. HCP: Which Stock Is the Better Value Option?
HCP Prices Upsized Public Offering of 15M Common Shares
by Zacks Equity Research
HCP increases public offering of common stock to 15 million shares, and enters into a forward sale agreement for 13 million shares as well.
HCP (HCP) Up 2.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
HCP (HCP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
HPT vs. HCP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HPT vs. HCP: Which Stock Is the Better Value Option?
HCP (HCP) Surpasses Q3 FFO Estimates
by Zacks Equity Research
HCP (HCP) delivered FFO and revenue surprises of 2.33% and -0.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
HCP Tops Q3 FFO Estimates on NOI Growth, Misses on Revenues
by Zacks Equity Research
HCP's third-quarter performance indicates year-over-year growth in three-month cash SPP net operating income (NOI) for the company's total portfolio.
REITs Queued for Q3 Earnings on Oct 31: FRT, MAC & More
by Zacks Equity Research
Let's delve into the factors that will likely impact Q3 results of Federal Realty (FRT), Macerich (MAC), Realty Income (O), Mid America Apartment (MAA) and HCP.
Can Demographic Tailwinds Drive HCP's Earnings This Season?
by Zacks Equity Research
Amid growth in asking rents, HCP will likely report higher net operating income for its senior housing portfolio in the third quarter. However, higher interest cost may suppress the bottom line.
Crown Castle (CCI) to Post Q3 Earnings: What Lies Ahead?
by Zacks Equity Research
Crown Castle International's (CCI) Q3 top-line growth will likely be hindered by rapid adoption of the Voice over WiFi network by mobile handset manufacturers and wireless carriers.
INN vs. HCP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
INN vs. HCP: Which Stock Is the Better Value Option?
SL Green (SLG) to Post Q3 Earnings: What's in the Offing?
by Zacks Equity Research
SL Green Realty (SLG) will likely gain from its portfolio-repositioning and asset disposition efforts in Q3. Yet, fall in rental revenues may persist in the near term.
Can Portfolio Repositioning Aid HCP Amid Supply Concerns?
by Zacks Equity Research
HCP is making pronounced efforts to rationalize its portfolio and is on track with operator transitions. However, high supply of senior-housing assets may hurt the company's near-term performance.
PK vs. HCP: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PK vs. HCP: Which Stock Is the Better Value Option?
HCP (HCP) Q2 FFO and Revenues Surpass Estimates
by Zacks Equity Research
HCP (HCP) delivered FFO per share and revenue surprises of 2.17% and 0.50%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
HCP Q2 FFO Beats Estimates, Revenues Up Y/Y, '18 View Up
by Zacks Equity Research
HCP's Q2 performance highlights benefits from higher-than-expected revenue numbers.
REITs to Watch for Q2 Earnings on Aug 2: REG, AIV and HCP
by Zacks Equity Research
Are Regency (REG), Aimco (AIV) and HCP poised to beat Q2 estimates this earnings season?